XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Go back to XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary| (NASDAQ: XAIR) | Delayed: 4.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.48 | 52 Week High | $ | |||
| Open | $4.48 | 52 Week Low | $ | |||
| Day High | $4.48 | P/E | N/A | |||
| Day Low | $4.48 | EPS | $ | |||
| Volume | 7,195,127 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $1.75 | |||
| Open | $2.47 | 52 Week Low | $0.64 | |||
| Day High | $2.47 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $0.00 | |||
| Volume | 221 | |||||

